FIBCD1

Across TCGA pan-cancer cohorts, FIBCD1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated FIBCD1 data layer compared with 24 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher FIBCD1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated FIBCD1 expression acts as an unfavorable survival marker, although some lineages such as COAD and PDAC show a favorable association.

HNSC, GBM, and COAD are the cancer types where FIBCD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	IV	0.656	0.870	.007	32	view →
GBM	OS	Quartile	All	0.756	1.000	.006	10	view →
COAD	DFS	Median	IV	1.000	0.605	.043	6	view →
PDAC	DFS	Median	All	0.443	0.276	.021	6	view →
LSCC	DFS	Median	II,III,IV	0.849	0.972	.020	3	view →
LUAD	DFS	Quartile	All	0.509	1.000	.039	1	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

FIBCD1–HNSC (DFS)

Open the HNSC breakdown →